ObvioHealth Is Ready For Decentralized Trials To Continue Growth Post-Pandemic
ObvioHealth is redefining clinical trials with its remote approach to address poor-quality patient-reported data and high costs while simultaneously discovering new trial outcomes.
You may also be interested in...
Using artificial intelligence and strict data collection protocol, ObvioHealth hopes to digitize clinical trials with the assistance of medical devices and consumer technology.
In this month’s Digital Health roundup, Medtech Insight’s Reed Miller talks about iRhythm and Withings’ smartwatches business, Barnaby Pickering reviews digital therapeutics Pear Therapeutics’ restructuring, and Marion Webb presents highlights from her new series on Agetech.
The companies will link Abbott’s blood glucose monitoring devices to WeightWatchers’ smartphone apps and weight loss program.